Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 9
Submit an article Journal homepage
2,628
Views
3
CrossRef citations to date
0
Altmetric
Diabetes

Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes

Mark L. WarrenPhysicians East, Greenville, NC, USA; Correspondence[email protected]
,
Meryl BrodThe Brod Group, Mill Valley, CA, USA;
,
Jonas Håkan-BlochGlobal Market Access, Novo Nordisk A/S, Søborg, Denmark;
,
Thomas SparreMedical & Science Devices & Titration, Novo Nordisk A/S, Søborg, Denmark;
&
Louis B. ChaykinMeridien Research, Bradenton, FL, USA
Pages 1623-1629 | Received 19 Jun 2018, Accepted 21 Jan 2019, Published online: 21 May 2019

Related Research Data

Patient-reported outcomes (PRO) from a randomized, crossover trial comparing insulin degludec using FlexTouch® with insulin glargine U100 using SoloSTAR® pen-injectors in patients with type 2 diabetes
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.